Overview
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2001-12-17. Active
53 1600 1127 1846 7484 3000 0001- 26 1600 1127 1846 7484 3000 0002
- 69 1600 1127 1846 7484 3000 0004
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Real estate
| Type | Amount |
|---|---|
Buildings and premises | PLN 67,658PLN 67,658 |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Public sector contracts
Urgo is the contractor in 2 public sector contracts, worth PLN 1.56k in total. All of them were signed with the same public buyer.
| Public buyer | Value | |
|---|---|---|
| Śląski Uniwersytet Medyczny w Katowicach | PLN 1,104 | |
| Śląski Uniwersytet Medyczny w Katowicach | PLN 460.98 |
Trademarks
Urgo holds 22 active trademarks registered with the Polish Patent Office. 3 applications are pending. The first mark was filed in 1992.
| Mark | Protected until | |
|---|---|---|
| ALUGASTRIN BIONEO(word) | Jan 8, 2036 | |
| Resteeme Your Skin | Jul 11, 2034 | |
| MUCOREF ALUGASTRIN(word) | May 27, 2034 | |
| RESTEEME(word) | Jan 23, 2034 | |
| MELANESSE(word) | Aug 10, 2033 |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
The company is represented by one member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Belhyperion Nv | 230 | $77,350.08 | 60.0522% |
Laboratoires Urgo Healthcare | 153 | $51,454.62 | 39.9478% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
MybestpharmS.A. | 67,531.06 USD | 100% |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| ITPS.A. | $55,285,362.18 | itpsa.pl | ||
| Orkla CareS.A. | $43,777,691.06 | orklacare.com.pl | ||
| Idalia Ludwikowscysp. j. | $41,868,843.38 | idalia.com.pl | ||
| DiagnosisS.A. | $37,413,735.72 | diagnosis.pl | ||
| Medicussp. z o.o. | $36,028,857.15 | medicus.com.pl | ||
| Dermaticsp. z o.o. | $33,423,317.64 | dermatic.pl | ||
| Centrum Zaopatrzenia Medycznego Cezal - WrocławS.A. | $25,656,815.87 | cezal.com.pl | ||
| Synkmedsp. z o.o. | $20,634,200.47 | synkmed.pl | ||
| Intimexsp. z o.o. + limited partnership | $18,994,512.90 | intimex.com.pl | ||
| Ursapharm Polandsp. z o.o. | $16,296,973.60 | ursapharm.pl |
Change history
| Date | Event | |
|---|---|---|
| 2026-09-22 | Share capital change (190,485.00 PLN → 476,835.00 PLN) | |
| 2022-09-23 | Name change (Laboratoria Polfa Łódź → Urgo) | |
| 2018-02-05 | Share capital change (189,240.00 PLN → 190,485.00 PLN) | |
| 2017-11-27 | Address change (Trakt Lubelski 135, 04-790, Warszawa → Al. Aleje Jerozolimskie 142b, 02-305, Warszawa) | |
| 2017-11-27 | Name change (Bio-Profil Polska → Laboratoria Polfa Łódź) |
FAQ
Last updated: 2026-10-09